Switch to:

Sangamo Therapeutics EV-to-Revenue

: 12.55 (As of Today)
View and export this data going back to 2000. Start your Free Trial

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Sangamo Therapeutics's enterprise value is $1,001.19 Mil. Sangamo Therapeutics's Revenue for the trailing twelve months (TTM) ended in Mar. 2019 was $79.76 Mil. Therefore, Sangamo Therapeutics's EV-to-Revenue for today is 12.55.

NAS:SGMO' s EV-to-Revenue Range Over the Past 10 Years
Min: 2.3   Max: 52.3
Current: 12.54

2.3
52.3

During the past 13 years, the highest EV-to-Revenue of Sangamo Therapeutics was 52.30. The lowest was 2.30. And the median was 13.15.

NAS:SGMO's EV-to-Revenue is ranked higher than
50% of the 809 Companies
in the Biotechnology industry.

( Industry Median: 12.11 vs. NAS:SGMO: 12.54 )

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today, Sangamo Therapeutics's stock price is $11.60. Sangamo Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2019 was $0.79. Therefore, Sangamo Therapeutics's PS Ratio for today is 14.65.


Sangamo Therapeutics EV-to-Revenue Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Sangamo Therapeutics Annual Data

Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
EV-to-Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.00 10.96 4.00 32.66 9.51

Sangamo Therapeutics Quarterly Data

Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19
EV-to-Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.86 15.81 18.35 9.51 8.01

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Sangamo Therapeutics EV-to-Revenue Distribution

* The bar in red indicates where Sangamo Therapeutics's EV-to-Revenue falls into.



Sangamo Therapeutics EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Sangamo Therapeutics's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1001.189/79.759
=12.55

Sangamo Therapeutics's current Enterprise Value is $1,001.19 Mil.
Sangamo Therapeutics's Revenue for the trailing twelve months (TTM) ended in Mar. 2019 was 21.289 (Jun. 2018 ) + 23.562 (Sep. 2018 ) + 26.837 (Dec. 2018 ) + 8.071 (Mar. 2019 ) = $79.76 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Sangamo Therapeutics  (NAS:SGMO) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Sangamo Therapeutics's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=11.60/0.792
=14.65

Sangamo Therapeutics's share price for today is $11.60.
Sangamo Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2019 was 0.219 (Jun. 2018 ) + 0.232 (Sep. 2018 ) + 0.262 (Dec. 2018 ) + 0.079 (Mar. 2019 ) = $0.79.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Sangamo Therapeutics EV-to-Revenue Explanation


Sangamo Therapeutics EV-to-Revenue Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}